SCHEMBL9819484

SCHEMBL9819484

CCCCCOc1nc(Cl)nc2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.48
FAAH O00519 1/20 0.48
MGLL Q99685 1/20 0.48
ALDH1A1 P00352 3/20 0.48
KDM4E B2RXH2 2/20 0.48
GBA1 P04062 1/20 0.46
TOP2A P11388 1/20 0.46
GAA P10253 1/20 0.45
HTR1A P08908 2/20 0.44
HTR7 P34969 2/20 0.44
TLR8 Q9NR97 2/20 0.43
LMNA P02545 2/20 0.43
NPY1R P25929 1/20 0.43
NPY2R P49146 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 2/20 0.42
HPGD P15428 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3552942 0.84 L3MBTL1 (0.64) L3MBTL1ALDH1A1KDM4EGBA1GAA
Hydrochloric Acid SCHEMBL28406920 0.80 CYP1B1 (0.44) L3MBTL1ALDH1A1KDM4EGBA1TSHR
SCHEMBL7283175 0.78 MAPT (0.51) L3MBTL1FAAHMGLLALDH1A1KDM4E
SCHEMBL15147751 0.76 PDE5A (0.65) L3MBTL1ALDH1A1KDM4EGBA1LMNA
SCHEMBL28002627 0.75 TLR8 (0.54) L3MBTL1FAAHMGLLALDH1A1KDM4E
SCHEMBL1995850 0.75 NR1I3 (0.56) ALDH1A1KDM4EMAPTHPGDCYP1A2
SCHEMBL27294581 0.75 RAB9A (0.64) L3MBTL1FAAHMGLLALDH1A1KDM4E
SCHEMBL27374633 0.75 RAB9A (0.64) L3MBTL1FAAHMGLLALDH1A1KDM4E
SCHEMBL6722631 0.75 TLR8 (0.47) ALDH1A1KDM4EGAATLR8LMNA
SCHEMBL28407242 0.74 LMNA (0.43) L3MBTL1ALDH1A1KDM4EGBA1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0302967-B1 QUINAZOLINE DERIVATIVE, PROCESSES FOR ITS PRODUCTION, AND CEREBRAL DYSFUNCTION REMEDYING AGENT COMPRISING IT AS ACTIVE INGREDIENT KANEBO, LTD. (JP) 1991-10-30 EP disclosed
US-4877790-A NERVOUS SYSTEM DISORDERS; ALZHEIMER'S DISEASE KANEBO LIMITED (JP) 1989-10-31 US disclosed
EP-0302967-A2 Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient KANEBO, LTD. (JP) 1989-02-15 EP disclosed